agonistas adrenérgicos β
4-Hydroxy-α1-[[[6-(1-methyl-3-phenylpropoxy)hexyl]amino]methyl]-1,3-benzenedimethanol (Salmeterol Impurity)
CAS:108928-81-0
Applications 4-Hydroxy-α1-[[[6-(1-methyl-3-phenylpropoxy)hexyl]amino]methyl]-1,3-benzenedimethanol is an impurity of Salmeterol (S090100), a β2-Adrenergic agonist. Structural analog of Albuterol …
Fórmula:
C25H37NO4
Forma y color:
Neat
Peso molecular:
415.57
Ref: TR-H948170
25mg | 1.981,00 € | ||
2500µg | 308,00 € |
Entrega estimada en Estados Unidos, el Miércoles 18 de Diciembre de 2024
1-(2,4-Bis(benzyloxy)phenyl)ethanone
Producto controladoCAS:22877-01-6
Applications 1-(2,4-Bis(benzyloxy)phenyl)ethanone is a useful research chemical for organic synthesis and other chemical processes. References …
Fórmula:
C22H20O3
Forma y color:
Neat
Peso molecular:
332.39
Ref: TR-B521440
50mg | 91,00 € | ||
100mg | 101,00 € | ||
500mg | 244,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
O-Ethyl Albuterol
Producto controladoCAS:754926-25-5
Impurity Levalbuterol USP Related Compound E Applications O-Ethyl Albuterol is an analog of Albuterol (A514500). …
Fórmula:
C15H25NO3
Forma y color:
Neat
Peso molecular:
267.36
Ref: TR-E897500
25mg | 1.262,00 € | ||
2500µg | 276,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
6-(4-Phenylbutoxy)-1-hexanamine
CAS:97664-58-9
Applications 6-(4-Phenylbutoxy)-1-hexanamine is an intermediate in the synthesis of salmeterol (S090100), a structural analog of …
Fórmula:
C16H27NO
Forma y color:
Off White Solid
Peso molecular:
249.39
Ref: TR-P297920
100mg | 308,00 € | ||
250mg | 641,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
Formoterol (mixture of Diastereomers)
Producto controladoCAS:128954-45-0
Applications Formoterol is a selective β2-adrenergic receptor agonist. Formoterol is used as an antiasthmatic. References …
Fórmula:
C19H24N2O4
Forma y color:
Neat
Peso molecular:
344.40
Ref: TR-F693395
1mg | 324,00 € | ||
10mg | 2.136,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025